Largest pharmaceuticals by total assets
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Pfizer leads the 61 pharmaceuticals ranked by total assets, at CHF 175.2B, ahead of Johnson & Johnson (CHF 167.7B) and Sanofi (CHF 118.4B). Figures as of 18 Nov 2026, 14:51 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- PfizerCHF 175.2B
- Median
- CHF 3B
- Combined market value
- CHF 4.32T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Total assets ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | PfizerPFE · Health Care | CHF 175.2B | CHF 135.8B | CHF 23.83 | 0.54% down | 14% up | ||
| 2 | Johnson & JohnsonJNJ · Health Care | CHF 167.7B | CHF 561.4B | CHF 233.21 | 0.59% down | 38% up | ||
| 3 | SanofiSNY · Health Care | CHF 118.4B | CHF 96.1B | CHF 40.02 | 0.02% up | 4% down | ||
| 4 | Merck & CoMRK · Health Care | CHF 115.2B | CHF 291.7B | CHF 118.34 | 1.94% down | 51% up | ||
| 5 | AbbVieABBV · Health Care | CHF 112.8B | CHF 432.1B | CHF 244.44 | 0.84% down | 26% up | ||
| 6 | AstraZenecaAZN · Health Care | CHF 96B | CHF 235.5B | CHF 151.87 | 0.98% down | 2% up | ||
| 7 | Eli LillyLLY · Health Care | CHF 94.7B | CHF 1.06T | CHF 1,187.42 | 0.34% down | 35% up | ||
| 8 | NovartisNVS · Health Care | CHF 93.4B | CHF 250B | CHF 132.37 | 1.18% down | 25% up | ||
| 9 | Takeda PharmaceuticalTAK · Health Care | CHF 81.8B | CHF 57.8B | CHF 18.11 | 0.62% down | 54% up | ||
| 10 | Bristol-Myers SquibbBMY · Health Care | CHF 75.8B | CHF 104.3B | CHF 51.03 | 1.22% down | 34% up | ||
| 11 | Abbott LaboratoriesABT · Health Care | CHF 73B | CHF 152.7B | CHF 88.18 | 0.00% | 17% down | ||
| 12 | GSKGSK · Health Care | CHF 68.3B | CHF 83.1B | CHF 41.44 | 0.02% down | 6% up | ||
| 13 | Novo NordiskNVO · Health Care | CHF 67.8B | CHF 148.8B | CHF 33.77 | 1.43% down | 17% down | ||
| 14 | Teva Pharmaceutical IndustriesTEVA · Health Care | CHF 34.3B | CHF 42B | CHF 36.01 | 0.41% up | 74% up | ||
| 15 | Regeneron PharmaceuticalsREGN · Health Care | CHF 34.1B | CHF 83.7B | CHF 809.25 | 0.38% up | 36% up | ||
| 16 | ViatrisVTRS · Health Care | CHF 31.3B | CHF 19.8B | CHF 17.27 | 0.32% up | 96% up | ||
| 17 | Vertex PharmaceuticalsVRTX · Health Care | CHF 21.6B | CHF 114.5B | CHF 451.75 | 0.47% up | 27% up | ||
| 18 | GrifolsGRFS · Health Care | CHF 18.4B | CHF 5B | CHF 7.28 | 0.23% up | 1% up | ||
| 19 | Royalty PharmaRPRX · Health Care | CHF 16.5B | CHF 33.2B | CHF 57.72 | 0.16% down | 78% up | ||
| 20 | ZoetisZTS · Health Care | CHF 13B | CHF 28.8B | CHF 70.96 | 0.98% up | 29% down | ||
| 21 | Elanco Animal HealthELAN · Health Care | CHF 11.2B | CHF 11B | CHF 21.98 | 1.01% up | 20% up | ||
| 22 | GenmabGMAB · Health Care | CHF 10.8B | CHF 26.8B | CHF 43.52 | 0.50% down | 70% up | ||
| 23 | Jazz PharmaceuticalsJAZZ · Health Care | CHF 9.8B | CHF 13B | CHF 202.71 | 0.05% up | 37% up | ||
| 24 | BeOne MedicinesONC · Health Care | CHF 6.9B | CHF 39.1B | CHF 342.39 | 1.57% down | 17% up | ||
| 25 | United TherapeuticsUTHR · Health Care | CHF 6.6B | CHF 20.8B | CHF 488.77 | 0.59% down | 23% up | ||
| 26 | BioMarin PharmaceuticalBMRN · Health Care | CHF 6.4B | CHF 9.6B | CHF 49.41 | 0.32% up | 11% up | ||
| 27 | Dr. Reddy's LaboratoriesRDY · Health Care | CHF 5.2B | CHF 10.5B | CHF 12.59 | 1.15% up | 5% up | ||
| 28 | Roivant SciencesROIV · Health Care | CHF 4.8B | CHF 23.5B | CHF 32.49 | 0.28% down | 90% up | ||
| 29 | Alnylam PharmaceuticalsALNY · Health Care | CHF 4.2B | CHF 17.4B | CHF 130.10 | 1.24% down | 66% down | ||
| 30 | Amneal PharmaceuticalsAMRX · Health Care | CHF 3.1B | CHF 6.2B | CHF 17.83 | 0.28% up | 83% up | ||
| 31 | Ionis PharmaceuticalsIONS · Health Care | CHF 3B | CHF 3.8B | CHF 22.79 | 0.43% up | 64% down | ||
| 32 | PTC TherapeuticsPTCT · Health Care | CHF 2.4B | CHF 4.2B | CHF 50.53 | 0.55% down | 20% down | ||
| 33 | AlkermesALKS · Health Care | CHF 2.1B | CHF 6.5B | CHF 38.88 | 1.63% up | 58% up | ||
| 34 | InsmedINSM · Health Care | CHF 1.9B | CHF 22.4B | CHF 102.03 | 0.53% down | 40% down | ||
| 35 | Legend BiotechLEGN · Health Care | CHF 1.5B | CHF 2.7B | CHF 13.90 | 2.52% up | 42% down | ||
| 36 | Ligand PharmaceuticalsLGND · Health Care | CHF 1.3B | CHF 4.9B | CHF 247.22 | 0.03% down | 43% up | ||
| 37 | Ascendis PharmaASND · Health Care | CHF 1.2B | CHF 14.8B | CHF 225.36 | 1.27% down | 28% up | ||
| 38 | CytokineticsCYTK · Health Care | CHF 1.2B | CHF 6.1B | CHF 43.68 | 0.46% up | 20% down | ||
| 39 | Arrowhead PharmaceuticalsARWR · Health Care | CHF 1.2B | CHF 5.1B | CHF 36.08 | 0.29% down | 10% up | ||
| 40 | Madrigal PharmaceuticalsMDGL · Health Care | CHF 1.1B | CHF 8.1B | CHF 349.88 | 1.50% down | 24% down | ||
| 41 | TG TherapeuticsTGTX · Health Care | CHF 895M | CHF 8B | CHF 52.83 | 0.10% up | 107% up | ||
| 42 | Praxis Precision MedicinesPRAX · Health Care | CHF 789.5M | CHF 7.2B | CHF 256.54 | 0.09% down | 61% up | ||
| 43 | Cogent BiosciencesCOGT · Health Care | CHF 789.2M | CHF 4.1B | CHF 23.78 | 1.44% up | 20% down | ||
| 44 | BridgeBio PharmaBBIO · Health Care | CHF 787.9M | CHF 12.5B | CHF 64.42 | 0.35% down | 17% up | ||
| 45 | Mirum PharmaceuticalsMIRM · Health Care | CHF 709.4M | CHF 5.1B | CHF 77.43 | 0.04% up | 31% up | ||
| 46 | Corcept TherapeuticsCORT · Health Care | CHF 704.2M | CHF 6.4B | CHF 58.36 | 1.05% down | 8% down | ||
| 47 | Belite BioBLTE · Health Care | CHF 657M | CHF 5.4B | CHF 133.83 | 0.81% up | 31% up | ||
| 48 | Spyre TherapeuticsSYRE · Health Care | CHF 654.7M | CHF 7.6B | CHF 79.55 | 0.75% up | 286% up | ||
| 49 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | CHF 642.8M | CHF 6.4B | CHF 81.43 | 1.71% up | 126% up | ||
| 50 | Summit TherapeuticsSMMT · Health Care | CHF 632.3M | CHF 7.2B | CHF 9.03 | 0.56% up | 36% down | ||
| 51 | Axsome TherapeuticsAXSM · Health Care | CHF 580.6M | CHF 5.9B | CHF 113.01 | 1.24% down | 7% down | ||
| 52 | Protagonist TherapeuticsPTGX · Health Care | CHF 562.4M | CHF 6.8B | CHF 104.47 | 0.45% down | 46% up | ||
| 53 | ABIVAXABVX · Health Care | CHF 545.7M | CHF 6.1B | CHF 70.22 | 1.61% up | 27% down | ||
| 54 | Travere TherapeuticsTVTX · Health Care | CHF 509.4M | CHF 4.1B | CHF 42.36 | 1.51% down | 44% up | ||
| 55 | Edgewise TherapeuticsEWTX · Health Care | CHF 465.1M | CHF 3.8B | CHF 34.54 | 2.40% down | 88% up | ||
| 56 | Dianthus TherapeuticsDNTH · Health Care | CHF 446.9M | CHF 4.1B | CHF 72.91 | 0.41% down | 113% up | ||
| 57 | Oruka TherapeuticsORKA · Health Care | CHF 411.3M | CHF 5.6B | CHF 81.99 | 1.13% up | 241% up | ||
| 58 | Rhythm PharmaceuticalsRYTM · Health Care | CHF 404.2M | CHF 6.7B | CHF 96.72 | 1.46% down | 13% up | ||
| 59 | Definium TherapeuticsDFTX · Health Care | CHF 370.4M | CHF 3.4B | CHF 24.63 | 0.41% down | 169% up | ||
| 60 | ErascaERAS · Health Care | CHF 333.5M | CHF 4B | CHF 11.30 | 3.38% down | 403% up | ||
| 61 | VeradermicsMANE · Health Care | CHF 128.5M | CHF 4.5B | CHF 106.52 | 0.72% up | 233% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 0.8417 CHF).
Questions and answers
Which pharmaceuticals rank first by total assets?
Pfizer (CHF 175.2B), Johnson & Johnson (CHF 167.7B) and Sanofi (CHF 118.4B) are the top three of the 61 pharmaceuticals ranked by total assets as of 18 Nov 2026, 14:51 UTC.
How many pharmaceuticals are in this ranking?
61 are ranked by total assets.
What are these pharmaceuticals worth together?
The 61 pharmaceuticals ranked by total assets have a combined market value of CHF 4.32T as of 18 Nov 2026, 14:51 UTC.
What does ranking by total assets measure?
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceuticals by total assets”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=total-assets
Underlying data: Yahoo Finance; SEC EDGAR.